You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Table 1. Comparison Between Laser Therapy and Amnioreduction.  

CME

Treatment of Twin-Twin Transfusion Syndrome

  • Authors: A. Cristina Rossi, MD
  • CME Released: 10/12/2012
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 10/12/2013
Start Activity


Target Audience and Goal Statement

This activity is intended for obstetrician gynecologists and other physicians who manage multiple pregnancies.

The goal of this activity is to evaluate interventions for pregnant women with TTTS.

Upon completion of this activity, participants will be able to:

  1. Distinguish ultrasound findings characteristic of TTTS
  2. Evaluate interventions to reduce amniotic volume in cases of TTTS
  3. Assess the efficacy and safety of laser therapy for TTTS
  4. Compare techniques of selective infanticide in cases of TTTS


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author

  • A. Cristina Rossi, MD

    Department of Obstetrics and Gynecology, University of Bari, Bari, Italy

    Disclosures

    Disclosure: A. Cristina Rossi, MD, has disclosed no relevant financial relationships.

Editor

  • Elisa Manzotti

    Publisher, Future Science Group, London, United Kingdom

    Disclosures

    Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine

    Disclosures

    Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.

CME Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • his activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Expert Reviews Ltd. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Treatment of Twin-Twin Transfusion Syndrome: Septostomy

processing....

Septostomy

Septostomy is the intentional rupture of the intertwin septum by ultrasound guidance and is aimed at balancing the amniotic fluid pressure in the two sacs leading to a correction of the placental circulation, mainly in the donor twin’s vessels. In addition, filling the amniotic sac of the donor twin decreases cord compression, improves fetal hemodynamics and increases urine production by the donor twin.[10] Similarly, in serial amnioreduction, septostomy has the disadvantage of removing the clinical sign (polyhydramnios) but not the etiology of TTTS (placental anastomoses). Adverse effects of septostomy are similar to those described for serial amnioreduction, such as preterm labor and premature rupture of membranes. An additional risk is represented by the creation of a monoamniotic pregnancy that can be associated with cord entanglement. The incidence of survival rate following septostomy for TTTS varies widely from 36[10] to 83%.[11] A possible explanation might be the differing severity of TTTS at the time of intervention. Although there is a trend toward increasing gestational age at delivery with septostomy compared with amnioreduction,[12] a randomized trial of amnioreduction versus septostomy showed that overall perinatal survival was similar between the two groups, and septostomy offered the advantage of requiring a single procedure.[13]

Because of lower survival rates and higher risk of neonatal morbidity compared with laser therapy, septostomy is not commonly performed as treatment of TTTS.